Manuel Rubio‐Rivas

3.0k total citations
34 papers, 693 citations indexed

About

Manuel Rubio‐Rivas is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Manuel Rubio‐Rivas has authored 34 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Manuel Rubio‐Rivas's work include COVID-19 Clinical Research Studies (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Long-Term Effects of COVID-19 (9 papers). Manuel Rubio‐Rivas is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Long-Term Effects of COVID-19 (9 papers). Manuel Rubio‐Rivas collaborates with scholars based in Spain, Germany and Iran. Manuel Rubio‐Rivas's co-authors include Xavier Corbella, Carmen Pilar Simeón‐Aznar, Vicent Fonollosa, Cristina Royo, Rafael Moreno, Joaquim Marcoval, Narcı́s Homs, Françesc Formiga, Juan Mañá and Ramón M. Pujol and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Manuel Rubio‐Rivas

28 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Rubio‐Rivas Spain 12 323 309 188 158 109 34 693
Roozbeh Sharif United States 13 299 0.9× 348 1.1× 57 0.3× 184 1.2× 75 0.7× 20 666
Maria‐Magdalena Balp Switzerland 23 419 1.3× 124 0.4× 167 0.9× 323 2.0× 280 2.6× 68 1.2k
Punyasha Roul United States 12 61 0.2× 198 0.6× 129 0.7× 89 0.6× 10 0.1× 35 508
Douglas White New Zealand 16 146 0.5× 54 0.2× 36 0.2× 78 0.5× 54 0.5× 61 775
Kazuma Nagata Japan 22 53 0.2× 1.2k 3.8× 152 0.8× 171 1.1× 10 0.1× 70 1.6k
Leen Gilles United States 14 26 0.1× 412 1.3× 434 2.3× 280 1.8× 26 0.2× 15 1.0k
Kristin M. D’Silva United States 16 65 0.2× 97 0.3× 26 0.1× 95 0.6× 96 0.9× 41 885
Madan Raj Aryal United States 17 75 0.2× 165 0.5× 22 0.1× 80 0.5× 18 0.2× 59 898
Ajay Dhaygude United Kingdom 14 49 0.2× 182 0.6× 155 0.8× 40 0.3× 10 0.1× 47 677
László Romics United Kingdom 20 261 0.8× 151 0.5× 34 0.2× 83 0.5× 59 0.5× 59 1.3k

Countries citing papers authored by Manuel Rubio‐Rivas

Since Specialization
Citations

This map shows the geographic impact of Manuel Rubio‐Rivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rubio‐Rivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rubio‐Rivas more than expected).

Fields of papers citing papers by Manuel Rubio‐Rivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Rubio‐Rivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rubio‐Rivas. The network helps show where Manuel Rubio‐Rivas may publish in the future.

Co-authorship network of co-authors of Manuel Rubio‐Rivas

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Rubio‐Rivas. A scholar is included among the top collaborators of Manuel Rubio‐Rivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Rubio‐Rivas. Manuel Rubio‐Rivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Marateb, Hamid Reza, et al.. (2024). Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE). Life. 14(9). 1195–1195.
4.
Hazard, Derek, Hamid Reza Marateb, Marjan Mansourian, et al.. (2024). Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential. Frontiers in Medicine. 11. 1362192–1362192. 4 indexed citations
5.
Pardos‐Gea, José, Manuel Rubio‐Rivas, Francesca Mitjavila, et al.. (2023). Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing. International Journal of Molecular Sciences. 24(22). 16372–16372. 2 indexed citations
6.
Rubio‐Rivas, Manuel, et al.. (2023). Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave. Revista Clínica Española (English Edition). 223(5). 298–309.
7.
Hazard, Derek, Hamid Reza Marateb, Camille Maringe, et al.. (2023). Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data. BMC Medical Research Methodology. 23(1). 197–197. 3 indexed citations
8.
Rubio‐Rivas, Manuel, et al.. (2023). Pacientes con EPOC hospitalizados por COVID-19 en España: comparación entre la primera y la segunda ola. Revista Clínica Española. 223(5). 298–309.
9.
Giner, V., Francisco Pomares, José A. Quesada, et al.. (2022). C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines. 10(6). 1393–1393. 7 indexed citations
10.
Pérez‐Belmonte, Luis M., et al.. (2022). Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y fibrilación auricular: datos del registro SEMI-COVID-19. Medicina Clínica. 159(10). 457–464. 5 indexed citations
11.
Pérez‐Belmonte, Luis M., et al.. (2022). Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry. Medicina Clínica (English Edition). 159(10). 457–464. 2 indexed citations
12.
Mora‐Luján, José María, Abelardo Montero, Françesc Formiga, et al.. (2021). High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis. Journal of Clinical Medicine. 10(19). 4465–4465. 7 indexed citations
13.
Sanz‐Cánovas, Jaime, Luis M. Pérez‐Belmonte, Lidia Cobos-Palacios, et al.. (2021). Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain. Revista Clínica Española (English Edition). 222(5). 255–265. 5 indexed citations
14.
Rubio‐Rivas, Manuel. (2021). Nationwide and international registries on scleroderma. Past, present, and future. SHILAP Revista de lepidopterología. 1(3).
15.
Rubio‐Rivas, Manuel, et al.. (2020). The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis. Autoimmunity Reviews. 20(1). 102713–102713. 33 indexed citations
16.
Rubio‐Rivas, Manuel & Xavier Corbella. (2020). Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients. European Journal of Internal Medicine. 77. 59–65. 18 indexed citations
17.
Rubio‐Rivas, Manuel, Jonathan Franco, & Xavier Corbella. (2019). Sarcoidosis presenting with and without Löfgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691 patients. Joint Bone Spine. 87(2). 141–147. 22 indexed citations
18.
Rubio‐Rivas, Manuel, Xavier Corbella, & Juan Mañá. (2019). Elderly sarcoidosis: A comparative study from a 42-year single-centre experience. Respiratory Medicine. 152. 1–6. 11 indexed citations
19.
Mañá, Juan, Manuel Rubio‐Rivas, Joaquim Marcoval, et al.. (2017). Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis. Medicine. 96(29). e7595–e7595. 81 indexed citations
20.
Rubio‐Rivas, Manuel, Joan Gómez‐Junyent, Antonella F. Simonetti, et al.. (2012). Nefritis lúpica mesangial proliferativa: descripción de una cohorte de 27 pacientes. Medicina Clínica. 139(8). 341–345. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roozbeh Sharif Breakdown of academic impact, for papers by Maria‐Magdalena Balp Breakdown of academic impact, for papers by Punyasha Roul Breakdown of academic impact, for papers by Douglas White Breakdown of academic impact, for papers by Kazuma Nagata Breakdown of academic impact, for papers by Leen Gilles Breakdown of academic impact, for papers by Kristin M. D’Silva Breakdown of academic impact, for papers by Madan Raj Aryal Breakdown of academic impact, for papers by Ajay Dhaygude Breakdown of academic impact, for papers by László Romics
Rankless by CCL
2026